These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


470 related items for PubMed ID: 8892617

  • 1. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B, Jaklic B, Harlan DM, Gray GS, June CH, Abe R.
    J Immunol; 1996 Nov 01; 157(9):3869-75. PubMed ID: 8892617
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T, Duschek K, Wahl C, Heeg K, Wagner H.
    Eur J Immunol; 1993 Jul 01; 23(7):1494-500. PubMed ID: 8325325
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

  • 4. Protection against lethal toxic shock by targeted disruption of the CD28 gene.
    Saha B, Harlan DM, Lee KP, June CH, Abe R.
    J Exp Med; 1996 Jun 01; 183(6):2675-80. PubMed ID: 8676089
    [Abstract] [Full Text] [Related]

  • 5. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.
    Kum WW, Cameron SB, Hung RW, Kalyan S, Chow AW.
    Infect Immun; 2001 Dec 01; 69(12):7544-9. PubMed ID: 11705931
    [Abstract] [Full Text] [Related]

  • 6. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T, Wahl C, Heeg K, Wagner H.
    J Immunol; 1993 May 01; 150(9):3776-84. PubMed ID: 8473732
    [Abstract] [Full Text] [Related]

  • 7. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
    Kum WW, Hung RW, Cameron SB, Chow AW.
    J Infect Dis; 2002 Feb 15; 185(4):555-60. PubMed ID: 11865410
    [Abstract] [Full Text] [Related]

  • 8. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P, Haller C, McConnell F.
    Eur J Immunol; 1996 Apr 15; 26(4):858-62. PubMed ID: 8625979
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis.
    McIntosh KR, Linsley PS, Drachman DB.
    Cell Immunol; 1995 Nov 15; 166(1):103-12. PubMed ID: 7585970
    [Abstract] [Full Text] [Related]

  • 12. T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion.
    Florquin S, Amraoui Z, Goldman M.
    Eur J Immunol; 1995 May 15; 25(5):1148-53. PubMed ID: 7774618
    [Abstract] [Full Text] [Related]

  • 13. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G, Hillman D, Levy R, Kaempfer R.
    J Leukoc Biol; 2001 Jun 15; 69(6):921-7. PubMed ID: 11404377
    [Abstract] [Full Text] [Related]

  • 14. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS, Penninger JM, Kündig T, Khoo W, Ohashi PS, Kroemer G, Mak TW.
    Eur J Immunol; 1996 May 15; 26(5):1074-82. PubMed ID: 8647170
    [Abstract] [Full Text] [Related]

  • 15. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA, Olsson C, Kalland T, Newton D, Kotb M, Dohlsten M.
    J Immunol; 1996 Oct 01; 157(7):2857-63. PubMed ID: 8816390
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
    Micusan VV, Mercier G, Bhatti AR, Reiser RF, Bergdoll MS, Oth D.
    Immunology; 1986 Jun 01; 58(2):203-8. PubMed ID: 3486824
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.